- Sumitomo Pharma (Harrisburg, PA)
- …seeking a dynamic, highly motivated, and experienced individual for the position of Associate Director , Market Access Engagement - Rare Disease, who will act ... pharmacy vendor management experience highly preferred; experience in supporting Cell and Gene therapy administered by a designated health care professional in a… more
- CSL Behring (King Of Prussia, PA)
- The Associate Director , Commercial Data Science & AI is crucial in driving the overall strategy for (Gen)AI tools and technologies within CSL. This individual ... role you will be reporting in to the Senior Director of Commercial Business Analytics Reporting & Data Science....scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued… more
- CSL Behring (King Of Prussia, PA)
- The Associate Director , L&G is responsible for collaborating closely with NA Operations leadership to develop curricula in line with CSL core values and ... three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and… more
- CSL Behring (King Of Prussia, PA)
- The Associate Director (AD), Biostatistics, leads the full scope of statistical contribution to a clinical development program. The AD provides statistical ... three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and… more
- CSL Behring (King Of Prussia, PA)
- The ** Associate Director , Field Reimbursement Manager Resourcing (FRM), US Portfolio,** is responsible for developing and implementing in office resources and ... three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and… more
- CSL Behring (King Of Prussia, PA)
- The Associate Director of Business Analytics US I&A is data and analytics leader in support CSL's brand teams with strategic insight through quantitative ... three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and… more
- CSL Behring (King Of Prussia, PA)
- …three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and ... collaboration across the enterprise. Under the guidance of the Publications Director , you will partner with Medical Affairs leaders, Compliance, Clinical, HEOR,… more
- CSL Behring (King Of Prussia, PA)
- …three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and ... collection and submit all reports needed for compliance. 4. Work with Senior Director , Policy Advocacy & Government Affairs, & Legal to interpret and implement… more
- CSL Behring (King Of Prussia, PA)
- …three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and ... continually refine ways in which products can address unmet medical needs and help patients lead full lives. CSL Behring operates one of the world's largest plasma collection networks, CSL Plasma (http://www.cslplasma.com) . Our parent company, CSL… more
- CSL Behring (King Of Prussia, PA)
- …three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and ... continually refine ways in which products can address unmet medical needs and help patients lead full lives. CSL Behring operates one of the world's largest plasma collection networks, CSL Plasma (http://www.cslplasma.com) . Our parent company, CSL… more